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1. Introduction 
Aortic valve stenosis constitutes 3-6% of congenital heart diseases with an incidence of 1-4 
per 10,000 live births (Khalid et al, 2006). The prevalence of aortic stenosis at birth is 0.03% 
(Mahle et al, 2010). If left untreated, it can lead to considerable morbidity and mortality in 
neonates, infants, children and adults.   
Until three decades ago, the only treatment that could be offered to children with aortic stenosis 
was surgical valvotomy and valve replacement in adults. In 1983 balloon valvuloplasty was 
introduced as the initial palliation of choice for aortic valve stenosis in children and adolescents. 
Later in 1985, the procedure was extended to infants with critical aortic stenosis (Pass & 
Hellenbrand, 2002). Over the past 25 years advancement in technique and equipment has 
radically improved the safety and outcome of balloon valvuloplasty of aortic valve. 
Pathologically the stenosed aortic valve may be tricuspid (trileaflet), bicuspid or unicuspid 
(Fernandes et al, 2007). The latter is the result of failure of separation of the three leaflets 
with stenosis being centrally located. Rarely the annulus may be hypoplastic or secondary 
calcification may develop in children and adolescents. 
Bicuspid aortic valve is seen on 1-2% of general population (Bermudez, 2007). Natural 
history of bicuspid aortic valve is not well defined in children but has a spectrum ranging 
from critical stenosis to no stenosis or regurgitation (Han et al, 2007). After the fourth 
decade it can progress to aortic stenosis and regurgitation due to thickening, fibrosis and 
calcification, imparting rigidity to the fused cusps or due to infective endocarditis. There is 
associated aortopathy with bicuspid aortic valves, in adults as well as children, in which 
dilatation of ascending aorta is seen increasing the incidence of aortic dissection. Factors 
related to aortic dilatation are severity of aortic stenosis and regurgitation and jet angle of 
left ventricular ejection (Mahle et al, 2010). 
2. Evaluation of aortic stenosis for intervention  
Neonates with critical aortic stenosis present with a low cardiac output syndrome or 
cardiogenic shock. The stenosis in neonates is considered “severe” if there is no arterial duct 
dependent systemic circulation in which case it is “critical”(Magee et al, 1997). In older 
children, pertinent clinical evaluation of severity of aortic stenosis includes presence of 
symptoms and signs of congestive cardiac failure, pulsus alternans, carotid shudder, 
reversed splitting of second heart sound and intensity of the ejection systolic murmur. 
Electrocardiogram is useful in noting the degree of left ventricular hypertrophy and strain.  
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Echocardiography offers the most reliable way of assessing suitability for catheter 
intervention and also to predict its outcome. Aortic valve morphology can be identified as 
tricuspid, bicuspid or unicuspid. In evaluating bicuspid aortic valve, echocardiographic 
appearance of vertical or horizontal commissural orientation is noted in parasternal short 
axis view in diastole which makes the cusps either left-right or anterior-posterior in location 
respectively. It would be worthwhile noting the raphe which denotes fusion of two leaflets 
in bicuspid aortic valve (Bermudez et al, 2007). The fusion is categorized as right-left fusion, 
right-non coronary fusion or left-non coronary fusion. Fusion of right and non-coronary 
cusp has a two fold increase in the probability of requiring intervention.  
Thick leaflets are characteristic of dysplastic aortic valve. 2-D measurements include left 
ventricular size in length, diameter, systole and diastole, functional assessment of left 
ventricle and aortic annulus diameter. The latter is measured at the hinge point in the 
parasternal long axis view. It is important to note the presence and severity of aortic 
regurgitation before patient selection for balloon valvuloplasty. Aortic regurgitation can be 
graded as mild, moderate or severe according to criteria mentioned elsewhere (Bonow et al, 
2008). Mitral valve disease and incompetence should be assessed. Doppler gradients across 
aortic valve, peak and mean, have to be measured. Previously exercise testing was used to 
grade severity of aortic valve stenosis. But the accuracy of echocardiography in evaluating 
severity has limited its use (Khalid et al, 2006).  
3. Indications for intervention  
According to AHA/ACC guidelines, aortic stenosis is graded as mild, moderate and severe 
on basis of hemodynamic and natural history data using basis of aortic jet velocity, mean 
pressure gradient and valve area (in adolescents and adults). Severe aortic stenosis is when 
the area is <1 cm², MPG is > 40mmHg and jet velocity is greater than 4 m/sec. Intervention 
should be done if the peak to peak gradient  is 50 mmHg in symptomatic and 60mmHg in 
the asymptomatic patients (Bonow et al, 2008). Additional indications include strain on 
electrocardiogram, presence of symptoms or LV dysfunction irrespective of gradients. 
Moderate or severe aortic regurgitation is a contraindication to valvuloplasty. 
4. Pre-catheterization stabilization 
In critically sick neonates and infants, stabilization should begin in the intensive care unit. 
All neonates, infants and children should be mechanically ventilated, controlled on 
temperature with warming mattress, optimized on acid-base and electrolyte balance, 
calcium and magnesium status, blood pressures and cardiac output. The latter is done with 
intravenous inotrope and prostaglandin infusion to maintain ductal patency in neonates. An 
arterial blood gas should be analyzed prior to the procedure. Blood products should be 
made available in case of complications. Antiarrhythmic drugs and defibrillator should be 
ready in case ventricular arrhythmias occur, as these patients are at a high risk for such 
complications due to catheter and wire manipulation particularly in a failing left ventricle 
(Pass & Hellenbrand, 2002). 
5. Balloon aortic valvuloplasty 
In neonates and children, balloon aortic valvuloplasty has become the palliative procedure 
of choice, preferred over open aortic valvotomy ( Weber et al, 2006; Egito et al, 1997; Knirsch 
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et al, 2008).The aim of balloon valvuloplasty is to relieve left ventricular outflow tract 
obstruction thereby improving cardiac output, myocardial hypertrophy and function 
(Bonow et al, 2008). Monitoring during the procedure includes hemodynamic non-invasive 
pulse oximetry, blood pressures and many clinicians advocate transesophageal 
echocardiography for guidance as well as hemodynamic monitoring. This would avoid over 
dilation of aortic valve and also provide a reliable noninvasive way of assessing aortic 
insufficiency without having to perform frequent ascending aortogram. 
5.1 Approach for valvuloplasty 
Historically, over the last 25 years, various approaches have been used for balloon 
valvuloplasty. These different catheter techniques have their own advantages and 
disadvantages and there is no consensus as to which is the optimal approach, particularly in 
neonates with critical aortic stenosis. Some of these have historical importance only. 
5.1.1 Retrograde umbilical artery approach 
Umbilical arterial approach was advocated by Beekman in 1991 in neonates with critical 
aortic stenosis. They found this method technically easier than transvenous antegrade 
approach particularly in cases with hypertrophied small left ventricle. This route also 
avoided injury to the femoral artery by large catheters available in those days (Beekman et 
al, 1988).  
The procedure involves canulating both the umbilical arteries with 4 or 5 French catheters 
and a transvenous catheter for gaining antegrade access to the left ventricle. The umbilical 
arteries were used for balloon dilation through one and monitor aortic pressure with the 
other. The transvenous catheter was used to perform left ventriculogram and monitor left 
ventricular pressures during the procedure. Egito et al reported their series of 33 cases 
with a 91% success with this route (Egito et al, 1997). Despite these successful studies, no 
recent reports are found with this technique presumably due to availability of better 
alternatives. 
5.1.2 Right scapular artery approach 
Reported in 1995 by Alekyan et al in a cohort of 21 infants, this procedure involves surgical 
exposure of the right axillary and subscapular artery with introduction of sheaths and 
balloon catheters. This route can accommodate larger catheters. Post procedure the incision 
is closed with sutures. Success rate was reported to be 68% by these authors with failures 
attributed to aberrant right subclavian artery or to technical difficulties caused by anatomy 
in small infants (Alekyan et al,1995). 
5.1.3 Transcarotid approach 
This approach was introduced by Fischer et al in 1990 as an alternate to retrograde femoral 
approach in critically ill neonates (Fischer et al, 1990; Maeno et al, 1997). The right carotid 
was surgically cut down and balloon catheter introduced. An 80-97% success rate was 
reported with complications occurring in 10% of patients (Weber et al ). These included 
significant blood loss, ventricular fibrillation and ventricular perforation. The carotid artery 
on follow up was found occluded in 3%, stenotic in 8% and patent in the remaining 89%. 
The approach has the advantage of ease of crossing the aortic valve and avoiding injury to 
femoral artery. 
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5.1.4 Transvenous antegrade approach 
This is favored by many clinicians because of the sparing effect on femoral artery and 
avoiding inadvertent perforation of aortic valve cusp. It was first introduced by Hausdorf in 
1993 (Hausdorf et al, 1993)  and then endorsed by several workers (Magee et al, 1997; Han et 
al 2007). The approach involves crossing of foramen ovale and entering the left ventricle. A 
loop is then formed using balloon tipped catheter to avoid mitral valve apparatus. The 
aortic valve is crossed antegradely over a wire thus avoiding injury to its cusps. This 
approach also ensures a relative stable position of the balloon during inflation without being 
forced out due to contractions. Risks involved include jeopardy of mitral valve apparatus 
producing mitral regurgitation, inherent risks of trans-septal puncture in a small infant or 
neonate if it has to be done, difficulty in directing the flow guided catheter towards the 
aortic valve in a small and hypertrophied left ventricle, and the threat of ventricular 
arrhythmias and perforation. 
5.1.5 Transfemoral retrograde approach 
This is the most commonly used method having the obvious advantage of easy access and 
straight catheter course. Balloons used initially were of high profile requiring large sheaths. 
There was a high risk of cusp perforation with the use of stiffer guide wires to cross the 
aortic valve (Weber et al, 2006). However with the improvement in technology, low profile 
balloons have significantly reduced the frequency of femoral arterial injury. The incidence of 
cusps perforation has also diminished with the use of floppy tipped guide wires.  
5.1.6 Double balloon technique: 
Use of double balloon is a modification of single balloon, originally proposed by Beekman et 
al in 1988. It is applicable when balloon valvuloplasty is performed in older children and 
young adults where the big size of single balloon would endanger the femoral artery. Both 
the femoral arteries are accessed and aortic valve is crossed twice from both sides in a 
retrograde fashion. Two balloons of the same size are chosen, the sum of their diameters 
amounting to 1.3 times the size of the aortic annulus. The two balloons are inflated 
simultaneously. The advantages are not only less injury to the two femoral arteries but also 
the crevice between two balloons avoids complete left ventricular outflow obstruction 
during balloon inflation. (Beekman et al, 1988) . 
5.2 Technical considerations 
Percutaneous technique for retrograde balloon aortic valvuloplasty involves femoral arterial 
and venous access. The bottleneck is access in neonates with critical aortic stenosis. 
Ultrasound guided percutaneous access is a good way to deal with such difficulties. The 
other option is to expose the artery through a surgical cut down. The femoral venous access 
is for insertion of a temporary pacemaker. A 3-4 Fr sheath initially for the artery and a 5Fr 
sheath for the vein are inserted using the modified Seldinger technique (Randolph et al). A 
temporary pacemaker is inserted in the right ventricle and the rate, output and sensitivities 
are determined before commencing the procedure for balloon dilation. The desired paced 
heart rate is the one that would reduce the systemic blood pressure by half. The concept of 
pacing to achieve tachycardia is to temporarily reduce the cardiac output in order to 
stabilize the balloon position during inflation (Leon et al, 2010; Marshall et al, 2005; Gupta et 
al, 2010). Another method of reducing cardiac output, very popular a decade ago, was to 
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inject intravenous adenosine rapidly to produce cardiac standstill (by inducing sinoatrial 
and atrioventricular block) to allow unproblematic balloon inflation (Karago et al, 2008). 
Many clinicians would not pace neonates particularly if the left ventricular function is 
decreased. 
With a pigtail catheter, an ascending aortogram is done. This helps in identifying and 
grading aortic regurgitation as well as measuring the aortic valve annulus diameter and jet 
width and direction. The thickness of valve leaflet is measured and classified on 
anteroposterior or lateral cineangiograms as thin (< 2mm) or thick (>2mm) (Egito et al, 
1997). The major impediment is crossing the stenosed, invariably eccentric orifice of the 
aortic valve. The catheter used for this purpose is usually pediatric right Judkin’s catheter or 
any other suitable catheter that would align itself to the jet direction. The aortic valve orifice 
is traversed with a floppy tipped guide wire. This would avoid valve perforation and 
crossing through the valve leaflet which was a problem encountered in early years. The 
initial guide wire to cross the aortic valve could either be a 0.014-in. coronary wire (C.R. 
Bard Inc.), a 0.035-in. flexible tipped wire (Wholey, Mallinckrodt Medical), a 0.035- or 0.018-
in. hydrophilic wire (Terumo Corp., Tokyo, Japan) or a 0.025-in. Teflon-coated wire (Cook 
Inc.) (Magee, 1997). 
 
 
Fig. 1. Retrograde balloon aortic valvuloplasty in an infant with a temporary pacemaker 
wire in place 
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Once across, depending upon the severity of stenosis and patient stability, the floppy guide 
wire is exchanged for a stiffer wire whose end has been shaped manually to make it curl 
inside the left ventricle. A left ventriculogram is done which would further define the aortic 
valve anatomy, degree of mitral regurgitation and left ventricular function. A low profile 
balloon whose size should be 80-90% of the aortic valve annulus diameter and 2-3 cm in 
length is selected and advanced across the aortic valve annulus. Rapid pacing is ensued and 
balloon inflated using 1/3rd to 1/4th diluted contrast, preferably with the help of an inflation 
device. This is a crucial part in which a controlled inflation is aimed at, looking for the 
appearance and disappearance of the waist, to avoid over dilation and producing aortic 
valve regurgitation (Figure 1). Some newer balloons have been designed with a double step 
dilation (example first 15mm and then 20 mm) (Berland et al, 1989) and may be of use in 
adolescents. 
Post dilation, catheters are changed and pressures measured again in the left ventricle and 
aorta, preferably with a multi-track catheter. If the left ventricular pressures are 
unacceptably high, re-dilation is done with the same balloon or sometimes with another 
balloon 1mm larger in size. A left ventriculogram is performed to relook at the aortic valve 
mobility, mitral regurgitation and left ventricular function (Magee et al, 1997). A post 
dilation aortogram is done to look at aortic regurgitation and jet width. 
5.3 Difficulties and complications 
Balloon aortic valvuloplasty like most interventional procedures is semi-blind. The major 
hindrance is crossing the aortic valve, particularly to be anticipated in neonates with critical or 
severe aortic stenosis. At times the guide wire crosses but the catheter or balloon catheter may 
not cross. In such a situation, pre-dilation with a small coronary balloon catheter is done.  
There is a risk of ventricular tachycardia and fibrillation due to irritation produced by guide 
wires and catheters placed in an ischemic left ventricle. Cardiac perforation can occur 
particularly if soft wires are not used. Femoral artery access, particularly in neonates, carries 
the risk of damage to the vessel, resulting in thrombosis and potential limb complications up 
to 39% (Pass & Hellenrand,2002; Magee et al, 1997; Egito et al !997). Aortic arch dissection 
flaps are seen during or post procedure and are related to use of stiffer wires or balloons 
with larger internal diameter lumen than the wire. This problem can be overcome to some 
extent by pre-shaping the guide wire. 
Mitral regurgitation is a complication after balloon valvuloplasty particularly with the 
antegrade approach, less commonly with the retrograde approach. This is mainly due to the 
catheter, guide wire and/or balloon catching on the mitral valve. In many patients the 
myomatous nature of the mitral valve and the small left ventricular cavity are compounding 
factors for this complication. Mitral and acute aortic regurgitation can lead to acute 
pulmonary edema. 
5.4 Poor outcome 
The results of balloon aortic valvuloplasty are considered suboptimal is the valve fails to 
dilate and there are residual Doppler gradients of more than 50 mmHg, moderate or severe 
aortic valve regurgitation, moderate or severe mitral valve regurgitation and worsening left 
ventricular function (Rao et al, 1989). 
Risk factors for poor results (residual gradients of >50mmHg) include older or neonatal age 
group, symptomatic patient (Knirsch et al. 2008), dysplastic aortic valves and left ventricular 
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dysfunction. The procedure is contraindicated in patients with associated moderate aortic 
regurgitation or hypoplastic left ventricle. Additional risk factors for poor outcome in a  
neonate include ductal dependency, mitral valve disease, notably stenosis, non-apex 
forming left ventricle, and hypoplastic aortic valve annulus (<6mm in diameter)(Knirsch et 
al, 2008). 
Mortality related to the procedure has been reported to be around 12%   mainly due to cusp 
perforation and avulsion producing severe regurgitation, and left ventricular perforation 
with guide wire. One study reported 46% mortality due to ventricular fibrillation, avulsion 
of aortic valve cusp and severe aortic regurgitation (Magee et al, 1997). This would lead to a 
sudden volume overload, together with reduced coronary perfusion of a poorly functioning 
or hypertrophied left ventricle  can rapidly lead to hypotension and acidosis  which can 
prove fatal.  
5.5 Aortic regurgitation  
The single complication to be avoided during balloon valvuloplasty is development or 
worsening of aortic regurgitation. Aortic regurgitation was caused by a combination of 
commissural avulsion, cusp dehiscence with retraction, cusp tear, central incompetence, 
perforated cusp, cusp prolapse,  or cusp adhesion to the aortic wall (Bacha et al, 2001; 
Balmer et al, 2004). There is a relationship of this complication to the use of oversized 
balloons. The dilemma faced in the catheterization laboratory is the decision on when to 
upsize (or not to upsize) the balloon, if residual gradients of 30 to 40 mm Hg are found. In 
older patients if residual gradients are high and the degree of aortic regurgitation is only 
mild or trivial, one can afford to upsize the balloon. However if residual gradients are <30 
mm Hg, there is very little to be gained in upsizing the balloon as aortic regurgitation would 
be produced. Furthermore, balloons usually are only available in 1- to 2-mm increments, 
making upsizing very risky. Holzer et al found that freedom from aortic valve replacement  
was not any worse (and potentially better) in patients with residual gradients of <35 mm Hg 
and moderate or severe aortic regurgitation compared with patients with residual gradients 
of >35 mm Hg and mild aortic regurgitation. This report should help in persuading 
operators to upsize the balloon if the gradient is 35 to 40 mm Hg with just mild aortic 
regurgitation, rather than a more conservative approach for fear of creating more aortic 
regurgitation (Holzer et al, 2010). 
It should be noted that even if the degree of aortic regurgitation is minimal immediately 
after balloon valvuloplasty, it does not remain so in the medium and long term follow up, it 
is usually progressive. Explanation for this phenomenon is that blood flow through the 
aortic valve leads to constant hemodynamic trauma to the valve tissue resulting in 
progressive tearing, scarring, retraction, and calcification of the valve (Balmer et al, 2004).  
5.6 Balloon aortic valvuloplasty in adults 
In symptomatic adolescents and adults with aortic stenosis, the procedure of choice is 
surgical therapy with either valve replacement or Ross procedure. Balloon aortic 
valvuloplasty may be offered to pregnant females to reduce the risks of pregnancy. It can 
also be offered to young adults with pliable valves who are not considered candidates for 
surgical therapy. Another group is adults who need stabilization before undergoing valve 
replacement. These are patients with severe aortic stenosis and poor left ventricular function 
who have symptoms of congestive heart failure. If not operated upon, they have a mortality 
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rate of 60% at 1 year. Although the exact place of the valvuloplasty procedure in the 
treatment of aortic stenosis in adults is yet to be determined, there is immediate clinical 
improvement in most of the patients with poor left ventricular function for whom surgery is 
not definitely contraindicated. It is therefore to be considered as a bridge to surgery in 
hemodynamically unstable patients to improve their operative risks (Berland et al, 1989; 
Singh et al, 2008). 
5.7 Balloon aortic valvuloplasty in special circumstances 
Balloon aortic valvuloplasty is done in all patients undergoing percutaneous valve 
implantation to allow the balloon- valve assembly to cross the aortic valve (Leon et al, 2010). 
Balloon aortic valvuloplasty has been attempted in stenosed surgical bioprostheses with 
mixed results in literature. Majority admit it has limited application with great caution in 
some instances and disappointment in others (Kirwan et al, 2004; Waller et al, 1991). The 
reason is that the bioprosthetic valve leaflets are at relatively high risk of tearing resulting in 
dehiscence, regurgitation or embolism. Lasting significant benefit has not been documented 
because of high incidence of restenosis (Webb J, 2011). Therefore repeat surgery or 
supportive medical therapy is advocated in such patients. It may be possible that the 
growing experience with percutaneous valve implantation may make the future of patients 
with failed bioprosthetic valves bright by ‘‘valve in valve’’ implantation. 
Balloon valvuloplasty can be done as a hybrid procedure with a trans-apical access in 
premature infants in whom peripheral vascular access may not be possible (Maschiettom et 
al, 2011). 
5.8 Balloon valvuloplasty for aortic stenosis in the fetus  
This is an evolving field with successful reports from several workers. The main idea is to 
improve left ventricular growth in cases of suspected hypoplasia of left ventricle (Marshall 
et al, 2005). Aortic stenosis is identified by fetal echocardiography. Noted are the thickness 
of the aortic valve leaflets, marked turbulence across the aortic valve and left ventricular 
dysfunction. Mothers undergo general anesthesia and are placed in an optimal position to 
obtain good ultrasound images. This position may be supine with required uterine 
displacement with external manipulation. Poor position may result in technical failure. In 
that case sometimes a mini laprotomy may be helpful and ultrasound being done directly 
per-uterine. The fetus is then given intramuscular anesthetic agent and muscle relaxant. 
Balloon size is determined by the aortic valve annulus and a balloon size can go up to 120%. 
A low profile coronary balloon catheter is chosen and mounted over a floppy tipped guide 
wire. The introducer is advanced through the fetal chest into the left ventricular cavity. The 
trocar is removed and intra ventricular position confirmed by the back flow of blood.  
The wire catheter assembly is passed through the canula until the wire is identified in the 
ascending aorta. The balloon is advanced and inflation done gently with an inflation device 
to achieve the required pressure. One or more inflations can be done, each not being for 
more than 5 seconds. The whole wire and catheter assembly is then withdrawn. 
The results are usually good with relief of gradient. It is difficult to determine the ideal 
balloon size. There is no way to measure decrease in gradient. Waist produced during 
inflation is not seen. One can appreciate improved flow across the aortic valve and 
appearance of new aortic regurgitation. In experimental animals, fetal aortic regurgitation 
occurring post balloon valvuloplasty led to hydrops fetalis. This complication has not been 
reported in human subjects. In fact aortic regurgitation can improve due to the remodeling 
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capacity of fetal aortic valve leaflets. Thus fetal aortic valvuloplasty has promising future for 
severe aortic stenosis. 
6. Clinical outcome of balloon aortic valvuloplasty at intermediate and long 
term follow up 
Intermediate and long term results of aortic valvuloplasty of congenital aortic valve stenosis 
in preventing or postponing aortic valve surgery are very good (Fratz et al, 2008). Survival 
after successful balloon valvuloplasty without significant residual stenosis or regurgitation 
has been reported to be 86% at 1 year and continues to remain the same until 10 years (Han 
et al, 2007). Left ventricular dysfunction improved in 87% on follow up (Egito et al, 1997). 
Incidence of re-intervention is variable and depends on the age of intervention and 
conservative interventional strategy used at the time of dilation. Pass et al reported a 64% 
freedom from re-intervention at 8 years follow up. A second re-dilation is usually required 
in neonates 1 month to 6 years after the initial procedure. Criteria for re-dilation would be 
the same as stated previously. Presence moderate or severe aortic regurgitation should 
preclude further balloon valvuloplasty (Khalid et al, 2006)1.  
Special reference must be made to neonatal severe or critical aortic stenosis which may be a 
different disease from congenital aortic stenosis treated later in life (Brown et al, 2010). The 
risk for both mortality and re-dilatation is higher in newborns with symptomatic aortic 
stenosis than in older infants, children, and adolescents or adults. Prime aim of dilating 
these frail neonates is to provide some relief of obstruction to allow the left ventricle to 
recover and at the same time avoid regurgitation. Therefore acceptable residual gradients 
may be higher in this group with an understanding that they may have recurrent aortic 
stenosis much earlier due to their rapid growth phase. 
Surgical intervention is required as a subsequent procedure when the aortic regurgitation is 
moderate to severe, or the valve is dysplastic and could not be dilated. In neonates and 
young children, surgical valvotomy for stenosis and repair for regurgitation are standard 
procedure. Aortic regurgitation is a complication of aortic valvotomy as well. Other surgical 
options are Ross operation or aortic valve replacement in older children. A significant 
number of patients after both aortic valvuloplasty and aortic valve surgery may require 
aortic valve replacement for progressive aortic regurgitation. Many non randomized 
comparisons have been made between results of aortic valvuloplasty and aortic valve 
surgery. The two were found comparable in terms of gradient relief, procedural mortality 
and long term survival. Therefore both procedures are essentially palliative. Consequently 
proponents of aortic valvuloplasty as an initial procedure can argue that with it the patient 
can benefit from one less surgery in their life (Knirsch et al, 2008). In one follow up data the 
freedom from aortic valve replacement was 79% at 10 years and 55% at 20 years (Brown et 
al, 2010 a). This becomes an important part of patient counseling while committing to care of 
patients with aortic valve stenosis. Those with severe left ventricular dysfunction and 
endocardial fibrosis may be candidates for cardiac transplant.  
The risk for late sudden cardiovascular death after balloon aortic valvuloplasty is not 
associated with acute post-procedural hemodynamic status. However, there are some 
significant predictors for the same, notably the presence of multiple left-heart  obstructive 
lesions. Patients undergoing balloon valvuloplasty in the neonatal period also have a higher 
risk for sudden cardiovascular death after balloon valvuloplasty, which may be a marker of 
more severe or progressive disease (Brown et al, 2010 b). 
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7. Percutaneous aortic valve implantation 
Calcific aortic stenosis is the most common valvular heart disease, affecting 2% to 4% of 
adults over age 65 in the United States. The prevalence of degenerative aortic stenosis 
increases with advancing age. It has a long asymptomatic phase, but when symptoms finally 
occur, clinical deterioration can be rapid with 50% mortality within two years of developing 
symptoms (Leon e al, 2010). Surgical aortic valve replacement is the gold standard therapy 
for adult patients with symptomatic severe aortic stenosis, be it congenital or degenerative 
in etiology. 
The steady increase in the number of patients requiring aortic valve replacement and the 
high surgical risk in patients with multiple co-morbidities have been driving the 
development of percutaneous techniques for the treatment of aortic stenosis. Other 
perceived advantages include less trauma, often faster recovery and fewer hospital days. 
There is a reluctance of some patients to undergo the trauma and pain associated with open 
heart surgery via sternotomy.  
It is estimated that for each two patients with severe symptomatic aortic stenosis 
undergoing surgical valve replacement, there is at least one patient who will never undergo 
surgery because of the perceived high risk. A recent study showed that 33% of patients over 
age 75 were deemed too high-risk for open heart surgery and thus were left untreated 
(Spargias et el, 2008).  
In 2002, Cribier al reported the first successful human percutaneous aortic valve 
implantation done antegradely via femoral vein. The approach had an inherent risk of 
mitral valve damage, ventricular perforation and tamponade. Thereafter the retrograde 
approach has become popular. Indications for percutaneous valve implantation are severe 
aortic stenosis with an aortic valve area of <0.8 cm2, MPG of>49 mmHg or a peak flow 
velocity of >4m/s (28). Pertinent exclusion criteria are bicuspid aortic valve, acute 
myocardial infarction, significant coronary artery disease, left ventricular ejection fraction 
less than 20%, diameter of aortic valve annulus less than 18mm or more than 25mm, severe 
aortic or mitral regurgitation and severe renal failure (Leon et al, 2008).  
Details of the technique and its application are described elsewhere. 
8. Conclusion  
Transcatheter treatment of congenital aortic valve stenosis is the intervention of choice in 
neonates, infants, children and also adolescents with good results. Valvuloplasty has a 
limited role in adults. Percutaneous aortic valve replacement has emerged as a therapeutic 
option in the elderly who are not candidates for surgical aortic valve replacement. 
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